Paediatric Consumer Health in Switzerland

Abstract
Sales of paediatric consumer health remain positive in 2022, albeit moderate. This growth is moderate because Swiss parents usually prefer usually to consult with their health practitioner when it comes to their children and seek help from professionals before resorting to medical recommendation that lead to prescription-based products. Parents only resort to self-medication for their children when they judge that the ailment is minor and does not need medical advice.

Euromonitor International's Paediatric Consumer Health in Switzerland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Paediatric Consumer Health in Switzerland

List Of Contents And Tables

PAEDIATRIC CONSUMER HEALTH IN SWITZERLAND
KEY DATA FINDINGS
2022 DEVELOPMENTS
Modest growth due to parents preferring to seek medical advice for their children
Paediatric analgesics and paediatric digestive remedies decline, due to parents being cautious about OTC for their children
PROSPECTS AND OPPORTUNITIES
Flat growth expected over the forecast period, due to ongoing parental caution
Galderma to remain the leading player in paediatric consumer health
The fear of future pandemics will likely benefit sales of paediatric vitamins and dietary supplements
CATEGORY DATA
Table 1 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 4 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
Table 5 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
Table 6 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 7 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN SWITZERLAND
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 9 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2017-2022
Table 11 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 12 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 13 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
Table 15 Distribution of Consumer Health by Format: % Value 2017-2022
Table 16 Distribution of Consumer Health by Format and Category: % Value 2022
Table 17 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Reverse Switches 2021-2022
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources